AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2018
Nov 27, 2018
34519_dirs_2018-11-27_0f0da18b-f4f2-4c88-8330-41b41e323273.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2018-11-26
Reporting Person: CRABB JOSEPH H (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-26 | Common Stock, par value $0.10 per share | D | 10766.0000 | $7.5000 | Disposed | 94345.0000 | Direct |
| 2018-11-26 | Common Stock, par value $0.10 per share | M | 47500.0000 | $1.7000 | Acquired | 141845.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-26 | Incentive Stock Options | $1.7000 | M | Disposed | 2019-01-08 | Common Stock (47500.0000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23